Latest Vitrafy Life Sciences (ASX:VFY) News

Page 4

Page 4 of 4

Vitrafy Life Sciences Accelerates Growth with $35M IPO and US Expansion

Vitrafy Life Sciences reports strong Q2 FY2025 progress, marked by a successful $35 million IPO, promising validation results in animal and human health, and strategic expansion into North America.

Victor Sage

31 Jan 2025